The First of Its Kind in the World: The Recombinant Multivalent COVID-19 Protein Vaccine against XBB Variants by WestVac Biopharma/West China Medical Center, Sichuan University has been Approved for Clinical Trials by The National Medical Products Administration of China

On May 17, 2023, Recombinant bivalent COVID-19 protein vaccine (Sf9 cells) and recombinant trivalent COVID-19 trimeric protein vaccine (Sf9 cells) developed by WestVac Biopharma/ West China Medical…

thaipr.net

19 พ.ค. 66

Blockchain tech innovation forum held in Chengdu

A forum focusing on the innovation and development of blockchain technology was held in Chengdu, the capital of Southwest China’s Sichuan province, on Nov 21. The Blockchain Technology Innovation and Development Forum, sponsored by the Chengdu municipal government, was a key part of the 2022 Chengdu Global Innovation and Entrepreneurship Fair and the second International Blockchain […]

thaipr.net

23 พ.ย. 65
1 2 3 4 5